<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The cause of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> remains unclear, or cryptogenic, in as many as 35% of patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Not knowing the cause of <z:hpo ids='HP_0001297'>stroke</z:hpo> restricts optimal implementation of prevention therapy and limits <z:hpo ids='HP_0001297'>stroke</z:hpo> research </plain></SENT>
<SENT sid="2" pm="."><plain>We demonstrate how gene expression profiles in blood can be used in conjunction with a measure of <z:mpath ids='MPATH_124'>infarct</z:mpath> location on neuroimaging to predict a probable cause in cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The cause of cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> was predicted using previously described profiles of differentially expressed genes characteristic of patients with cardioembolic, arterial, and lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="40" ids="33697">RNA</z:chebi> was isolated from peripheral blood of 131 cryptogenic <z:hpo ids='HP_0001297'>strokes</z:hpo> and compared with profiles derived from 149 <z:hpo ids='HP_0001297'>strokes</z:hpo> of known cause </plain></SENT>
<SENT sid="5" pm="."><plain>Each sample was run on Affymetrix U133 Plus 2.0 microarrays </plain></SENT>
<SENT sid="6" pm="."><plain>Cause of cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> was predicted using gene expression in blood and <z:mpath ids='MPATH_124'>infarct</z:mpath> location </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Cryptogenic <z:hpo ids='HP_0001297'>strokes</z:hpo> were predicted to be 58% cardioembolic, 18% arterial, 12% lacunar, and 12% unclear etiology </plain></SENT>
<SENT sid="8" pm="."><plain>Cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> of predicted cardioembolic etiology had more prior <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and higher CHA(2)DS(2)-VASc scores compared with <z:hpo ids='HP_0001297'>stroke</z:hpo> of predicted arterial etiology </plain></SENT>
<SENT sid="9" pm="."><plain>Predicted lacunar <z:hpo ids='HP_0001297'>strokes</z:hpo> had higher systolic and diastolic blood pressures and lower National Institutes of Health <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale compared with predicted arterial and cardioembolic <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Cryptogenic <z:hpo ids='HP_0001297'>strokes</z:hpo> of unclear predicted etiology were less likely to have a prior <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> or <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Gene expression in conjunction with a measure of <z:mpath ids='MPATH_124'>infarct</z:mpath> location can predict a probable cause in cryptogenic <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Predicted groups require further evaluation to determine whether relevant clinical, imaging, or therapeutic differences exist for each group </plain></SENT>
</text></document>